Tuesday, June 23, 2020
Monday, June 22, 2020
Investorideas.com - Health and Wellness Stock News: Neptune's (NASDAQ: $NEPT) (TSX: $NEPT.TO) New Natural, Plant-Based Hand Sanitizers to Launch in Club Store Channel
Investorideas.com - Health and Wellness Stock News: Neptune's (NASDAQ: $NEPT) (TSX: $NEPT.TO) New Natural, Plant-Based Hand Sanitizers to Launch in Club Store Channel
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 432 (CSE: $LIB.C) (NASDAQ: $NEPT) (TSX: $NEPT.TO) (TSXV: $N.V) (CSE: $BILZ.C) (NYSE: $IFF) (TSXV: $NRTH.V) (TSX: $AVCN.TO)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 432 (CSE: $LIB.C) (NASDAQ: $NEPT) (TSX: $NEPT.TO) (TSXV: $N.V) (CSE: $BILZ.C) (NYSE: $IFF) (TSXV: $NRTH.V) (TSX: $AVCN.TO)
Delta, Kelowna, BC, June 22, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/06221LIB-NEPT-N-BILZ-IFF-NRTH-AVCN.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public company announcements.
Liberty Leaf Holdings Ltd. (CSE: LIB)(OTC: LIBFF) announced that it has entered into an agreement with Nova Mentis Biotech Corp., pursuant to which LIB will acquire, by way of share exchange, 100 per cent of all of the issued and outstanding securities of NOVA.
Highlights of the Transaction:
● LIB gains NOVA's current net cash balance of approximately $1.2M CDN;
● Adds synergistic accompaniment to LIB's operating and licensed cannabis assets within the health and wellness sector;
● Bolsters roster of personnel who possess experience within scientific and R&D community; and
● Provides opportunity for intellectual property creation as NOVA advances its research mandate.
NOVA is a research and development driven company that is focused on investigating the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes. NOVA is of the view that its target indications represent vast and growing segments of the population. For example, in the United States, more than 10.5% of the population has Diabetes, which represents approximately 34.2 million people. Diabetes treatment can bare significant economic burden to patients with the average out of pocket monthly cost being estimated at $360 USD. According to a report by Fortune Business Insights, the global diabetes drug market size was valued at USD $48 Billion in 2018 and is projected to reach USD $78 Billion by 2026. Increasing societal prevalence of sedentary lifestyles coupled with vast access to inexpensive and nutritionally void food options are likely to contribute to further incidence of obesity and diabetes in the future. According to the National Center for Health Statistics, 39.8% of the US population aged 20 and over were considered obese in 2016, with an additional 31.8% being considered overweight. Obese individuals have a significantly higher incidence of depression (close to 30%) compared to the general population. Bidirectionally, according to the CDC, about 43% of depressed people are obese.
The strong therapeutic potential of psilocybin has emerged for a wide range of disorders, primarily mental health related. NOVA is focusing on a cohort group that has been very difficult to treat, both acutely and also in a sustainable way. This group of individuals have an overlap in two widespread and very important indications, obesity and depression. These comorbid conditions share inflammation as an important common mediator. NOVA's pre-clinical scientific study thus far is focused on targeting the gut-brain axis to modulate inflammation in this context. The aim is to utilize the unique properties of psilocybin to address both physiological and behavioural factors in obesity and comorbid depression.
NOVA was founded and is led by Dr. Aylia Mohammadi. Dr. Mohammadi obtained her PhD in Biological Physics from the Donnelly Centre for Cellular & Biomolecular Research at the University of Toronto, and subsequently completed a postdoctoral fellowship at the
Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital in Toronto. Aylia is a TEDx speaker, and has presented her work at international conferences. Her graduate training was inherently multidisciplinary, integrating techniques in molecular biology, neuroscience, and genetics. For her postdoctoral research, she examined underlying molecular mechanisms of inflammatory bowel disease, giving her a strong and relevant background to guide NOVA's scientific aims.
"Recent scientific advancement coupled with shifting opinions amongst, both the medical and general communities, at large regarding psychedelics including psilocybin make it a sector worthy of investment," stated Will Rascan, President and CEO of LIB. "Since our shift into cannabis in 2014, and our subsequent investment in Just Kush Enterprises Ltd, - now a holder of three Health Canada Cannabis Licenses – we have focused on emerging trends and shifting public awareness of natural based compounds for health and wellness, I believe this acquisition compliments our current legal cannabis portfolio and provides stakeholders with an early entrance in a new flourishing market."
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness company, announced today an expansion of its branded hand sanitizer product line.
Developed by Neptune Health & Wellness Innovations, in partnership with International Flavors & Fragrances (NYSE: IFF), the expanded product line consists of six new scented varieties, including Garden Mint, Fresh Linen, Orange Hibiscus, Eucalyptus, Fresh Lemon & Tea Tree, and Lavender. Neptune's products are natural, plant-based sanitizers made with a specialized blend of essential oils, aloe vera and fruit extract.
The expanded hand sanitizer product line is expected to launch in July in the club store channel through one of the largest retailers in the world. Neptune's partnership with IFF allows for rapid product development and delivery to retailers to ensure products are on the shelf and available to consumers. The Company expects expanded hand sanitizer revenues to be realized beginning in the second quarter of fiscal year 2021.
"We believe natural, plant-based products are the future as consumers pay increased attention to their health and wellness and use hand sanitizer products more frequently to prevent the spread of germs and bacteria," said Michael Cammarata, Chief Executive Officer of Neptune Wellness Solutions. "The expansion of our hand sanitizer product line through our partnership with IFF offers consumers a better experience with a variety of great scents, as well as essential oils and aloe vera to promote skin health. We look forward to increasing our distribution nationwide through our retail partnerships."
Nicolas Mirzayantz, IFF Divisional CEO, Scent, said, "We are proud to partner with Michael and his team on this timely and important product line. It is exciting to bring the talents of our perfumers and IFF's exceptional portfolio of natural and sustainable ingredients to create fragrances that help make keeping safe a better experience for consumers."
Neptune Health & Wellness Innovations is rapidly bringing new products to market to address market demand for critical health and wellness products such as the Neptune Halo oximeter, the Neptune Air non-contact thermometer, as well as hand sanitizer products and other innovations in development.
Namaste Technologies Inc. (TSXV: N) (OTC: NXTTF), a leading platform for cannabis products, accessories, and education, today announced CannMart Inc., a wholly owned subsidiary, has been granted an exclusive license by IGNITE International Brands, Ltd. (CSE: BILZ) (OTCQX: BILZF) to utilize certain brand trademarks on cannabis-based products for sale in the legal Canadian marketplace. In addition, CannMart has received approval from Alberta Gaming, Liquor & Cannabis and the Ontario Cannabis Retail Corporation operating as the Ontario Cannabis Store to begin offering Cannabis 2.0 products.
"Our agreement to become the exclusive distributor of IGNITE products in Canada is an important milestone for the company and positively reflects on our value proposition," said Meni Morim, CEO of Namaste Technologies. "CannMart continues to demonstrate its ability to grow its sales distribution channels in the Canadian market and this is attracting the attention of well-established brands like IGNITE. We place a high value on our relationships with these brands as it is our belief that brand recognition will be a major driver of growth as the legal industry matures and transitions to consumer-packaged goods. The opportunity for CannMart to be the exclusive distributor for IGNITE in Canada reinforces our position in the competitive cannabis market as consumers gravitate towards brands that are well known and trusted for their quality."
"The listing of Cannabis 2.0 products for the provinces of Ontario and Alberta is an important achievement and opens meaningful additional revenue channels. The Cannabis 2.0 market is a large addressable market and the approval to list our products in Alberta and Ontario, with more than 450 and 90 cannabis stores respectively, represents a substantial increase in the addressable market for CannMart. We expect to continue our recent sales success of cannabis products from premium brands, like IGNITE, through CannMart.com and throughout our network of government partners and retailers."
"Canada is an important market for IGNITE International Brands and CannMart has shown its ability to deliver high quality products to our target market," said Lester Lee, President of IGNITE. "The awareness of the IGNITE brand continues to build throughout Canada and our product sales continue to grow. The team at CannMart has been instrumental and has proven their competency to navigate the regulations within the legal market. We trust that our brand can be nurtured in accordance with our high standards and together we can continue to build on our early success as we look to grow market share."
Further to the news release of March 20, 2020, CannMart and IGNITE have amended the licensing agreement to add exclusivity to the markets in Canada. The revised agreement grants CannMart an exclusive licence to use certain IGNITE brand trademarks on legal cannabis-based products (the "IGNITE Products") in consideration for certain royalty payments. CannMart's introduction of IGNITE cannabis products has been welcomed by its customers and demand has continued to grow.
CannMart's listing of its first Cannabis 2.0 products in the provinces of Alberta and Ontario are now approved by both jurisdictions. CannMart's first offering will be a variety of vape cartridges. The AGLC is responsible for regulating and distributing cannabis to Alberta's licensed retailers and the sole legal online retailer for recreational cannabis at www.albertacannabis.org. The OCS is the sole legal online retailer and wholesaler for recreational cannabis for Canada's most populous province.
48North Cannabis Corp. (TSXV: NRTH) reported a successful first week of planting on Good:Farm, one of Canada's first and largest outdoor cannabis facilities.
Following the first season for licensed outdoor cultivation in Canada, 48North enters the upcoming season with improved know how, as well as operational and structural improvements to ensure that Good:Farm helps meet the steady demand for 48North products and positions itself to take advantage of opportunities for contract manufacturing partnerships.
"48North's commitment to cultivating outdoor, organic, sun-grown cannabis positions us to deliver the products our customers deserve in 2020," said Charles Vennat, CEO of 48North. "Without question, outdoor cultivation has been a game changer for the industry in terms of cost and quality. Last year, the Company learned important operational lessons in our season that will inform our 2020 approach. Our early mover advantage positions us to thrive in this space, while continuing to drive down cultivation costs below last year's benchmark of $0.25 per gram."
48North has taken the planting "off season" to focus on critical operational improvements at Good:Farm, including:
● Construction of a state-of-the-art drying facility on site, purpose built to be adapted for indoor cultivation in the winter (48North's licence amendment application was submitted for the drying facility on May 8th and early conversations with Health Canada leave the Company confident in its ability to receive approval in time for harvest);
● Leveraging genetics that succeeded outdoors in the first season at Good:Farm, through an in-house genetic breeding program,
● Introducing clone and tissue culture cultivation to Good:Farm, in addition to the Company's experience with seed stock;
● Expanding beyond Good:Farm's organic farming processes, with a specific focus on regenerative practices to nurture more resilient soils for nutrient-rich crops, this includes the consideration of the longevity and fertility of our farm;
● Recruiting new management with local know how and successful outdoor cannabis cultivation experience; and
● Emphasizing the Company's commitment to sustainability by eliminating single-use plastics in the production process.
Good:Farm's inaugural planting season demonstrated that high-quality, low cost cannabis for next generation cannabis products is best grown on a farm. Popular strains and products already on the market are the result of 48North's first harvest. The Company's added experience and operational upgrades will position it to build on this momentum and deliver on its initial vision of giving people the latitude to live well through high-quality cannabis products.
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, announced that on July 21st, 2020 it will be hosting a virtual symposium titled "Medical Cannabis 2.0" in partnership with Medical Cannabis by Shoppers. Patients and health care practitioners globally can join the virtual symposium to learn more about the potential advantages of medical cannabis and the advancement of product offerings including Avicanna's RHO Phyto product offerings and advanced cannabinoid research collaboration at the University of Toronto. In addition, experts will discuss the pharmacology, safety, and dosing guidelines of medical cannabis for therapeutic conditions. This includes presentations on the, efficacy of cannabinoids for chronic pain, anxiety, depression, and other comorbidities as well as an overview of the patient pathway to Medical Cannabis by Shoppers.
"In this unprecedent time, where patients and practitioners have many questions and are seeking alternative and natural solutions, we are pleased to welcome you all to our virtual symposium on medical cannabis. My talk on Common Medical Comorbidities will discuss how medical cannabis can be used for the management of clinical conditions that have common associated comorbidities of anxiety, depression and appetite and sleep disorders. Alongside my colleagues and collaborators, we hope you will find value in all our presentations and that they will provide important information, as patients and health care practitioners seeking to learn more about medical cannabis." – Dr. Amza Ali, Chief Medical Officer of Avicanna
Discussions will be led by clinicians and scientists from the Avicanna team as well as from prestigious Canadian academic and clinical research organizations including the University of Toronto and University Health Network's Toronto General Hospital.
The agenda for the virtual symposium is as follows:
● An Introduction to Cannabinoids and Their Pharmacology – Dr. Ruth Ross (Professor and Chair, Department of Pharmacology & Toxicology, Faculty of Medicine, University of Toronto, Senior Scientist, Campbell Family Mental Health Research Institute, CAMH)
● Advanced Cannabinoid Research and drug development at the University of Toronto – Dr. Pauric Bannigan (Post-Doctoral Fellow from Dr Christine Allen's laboratory at the Leslie Dan Faculty of Pharmacy, University of Toronto)
● Medical Cannabis 2.0 and Avicanna's RHO Phyto product offerings– Dr. Justin Grant (Executive Vice President of Scientific Affairs, Avicanna)
● The Potential of Cannabinoids for Chronic Pain – Dr. Hance Clarke (Staff Anesthesiologist
Director Pain Services, Director Good Hope Ehlers Danlos Clinic, Medical Director of The Pain Research Unit, Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Associate Professor, Department of Anesthesia, University of Toronto)
Director Pain Services, Director Good Hope Ehlers Danlos Clinic, Medical Director of The Pain Research Unit, Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Associate Professor, Department of Anesthesia, University of Toronto)
● Anxiety, Depression and Other Comorbidities in Patients to be Treated with Cannabinoids: Implications for Optimal Care – Dr. Amza Ali (Chief Medical Officer, Avicanna)
● An Introduction to Medical Cannabis by Shoppers Drug Mart – Neil D'Souza (Senior Manager, Operations, Medical Cannabis by Shoppers Drug Mart)
● The Future of Medical Cannabis Panel Discussion– (Aras Azadian, CEO of Avicanna Inc. / Pat McCutcheon, CEO MediPharm Labs / Kaveh Kahen, CEO of Sigma Analytics)
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800 665 0411
#Cannabis /#CBD #Stock News: American Green's (OTC: $ERBB) Smart Vending Machine called the "AGM"- Part of Growth Trend for Vending Machines During Pandemic; @American__Green
#Cannabis /#CBD #Stock News: American Green's (OTC: $ERBB) Smart Vending Machine called the "AGM"- Part of Growth Trend for Vending Machines During Pandemic; @American__Green
PHOENIX, AZ, June 22, 2020 (Investorideas.com newswire) – Breaking cannabis/CBD stock and sports news: American Green (OTC:ERBB) reported last month that EZ WEED has selected and purchased the company’s proprietary smart vending solution -- called the “AGM” -- as their “system of choice” for EZ Weed’s new business venture teaming up with prospective cannabis dispensaries throughout the nation.
Read this news featuring ERBB in full at https://www.investorideas.com/news/2020/cannabis/06221OTCERBB-SmartVendingMachine-AGM.asp
ERBB:Lindel Creed of American Green (OTC: $ERBB) chats with retired NFL Linebacker-turned-venture-capitalist Lamarr Houston and Lauren Smee of EZ Weed when visiting American Green's vending machine facility in Gastonia, NC.
According to recent news since their selection they are right on the money: “Reasons Why Vending Machines Are Gaining in Popularity- No Social Contact”
“With the current pandemic around the world, people prefer to purchase drinks and snacks from a machine, as it eliminates the need for human contact, which is one reason for the increased interest in vending machines.”
EZ Weed is run by Managing Partner, Lauren Smee and backed by retired NFL Linebacker-turned-venture-capitalist, Lamarr Houston. Mr. Houston, who played professionally for the Oakland Raiders and Chicago Bears, recently visited American Green’s AGM facility in Gastonia, NC. According to AGM Division Head, Lindel Creed, “It was obvious to me from the minute they both arrived at the AGM facility, that both Ms. Smee and Mr. Houston knew exactly which machine features they required for their venture and, by the time they left the facility, both were convinced that American Green could provide them.”
EZ WEED expects to purchase and supply the AGM Dispensing Vending Machines following their up-and-coming EZ Weed national launch and have already begun securing their location agreements with some of the top dispensaries in the US. According to Ms. Smee, “Our partnership with American Green is vital in reaching our goal of becoming the first national and mainstream marijuana vending machine provider and service. The automation, humanless sales method, and intelligent vending capabilities of the AGM will allow us to scale for high growth.”
EZ WEED was founded in January 2020. The company came to fruition organically through a love of cannabis and Ms. Smee’s extensive knowledge in launching startups -- with a new twist and groundbreaking sales method in the cannabis industry. The average sales process in a dispensary can be anywhere from 15-45 minutes. With EZ WEED, the entire process, even as a first-time user, is on average 3 to 5 minutes.
Besides the state-of-the-art machines, EZ WEED also provides its dispensary partners with “white glove” customer service as well as completely customizable digital marketing for each American Green AGM vending machine it provides. We do all the work pertaining to custom menus, product display, machine maintenance and a dedicated account manager that remotely keeps track of machine sales and inventory.
According to EZ Weed, serving cannabis users in an efficient manner has proven to be a challenge on a national level. With forward-thinking ideas and the backing of the venture capital firm, League Ventures, EZ WEED stands ready to enhance the sales process for new and seasoned cannabis users all across America. Please visit the websites of these two great companies by clicking on their names above.
American Green looks forward to a great long-term relationship with EZ WEED and believes that their expedient, reduced-human interaction is perfect for our country’s environment for today and years to come.
If you are an experienced vending route operator serving a major market and wish to add a complete line of fully legal CBD products to your existing route, you should contact Mr. Lindel Creed at American Green’s AGM Vending Division located in Gastonia, North Carolina. You can email Lindel at lindel@americangreen.com or call him on his direct line at 704-718-3158.
Shareholders and interest holders may also stay current with American Green Updates:
Twitter: @American__Green (two underscores), or
About American Green, Inc.
American Green, Inc. became, in 2009, America’s second publicly-traded company in the cannabis industry. American Green now, with its more than 50,000 individual certified shareholders, is one of the largest (in shareholder count) in the cannabis sector. American Green's mission is to lead the cannabis and premium CBD industry. Leveraging our team of professionals in cultivation management, manufacturing, extraction, wholesale, retail, and community outreach, we strive to develop sustainable initiatives in the cannabis-adjacent and CBD industries, laser-focused on adding company and shareholder value.
For more information -
Contact:
American Green, Inc.
Investor Relations
2902 W. Virginia Ave
Phoenix, AZ 85009
480-443-1600 X555
NOTES ABOUT FORWARD-LOOKING STATEMENTS
Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, be should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.
Paid news Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure : this news release featuring American Green (ERBB:OTC) is a paid for news release on Investorideas.com https://www.investorideas.com/News-Upload/
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
About Investorideas.com
Sign up for free stock news alerts at Investorideas.com
Friday, June 19, 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 431 (CSE: $DOSE.C) (OTCQB: $ALID) (CSE: $LHS.C) (CSE: $THC.C)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 431 (CSE: $DOSE.C) (OTCQB: $ALID) (CSE: $LHS.C) (CSE: $THC.C)
Delta, Kelowna, BC, June 19, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/06191DOSE-ALID-LHS-THC.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public and private company announcements.
Rapid Dose Therapeutics Corp. (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, announced that it has filed a non-provisional patent with the USPTO for an “Apparatus for and method of converting cbd and/or cbd derivatives to at least one other type of cannabinoid and/or cannabinoid derivative such as THC”. In conjunction with McMaster University and the team lead by Dr. James McNulty, RDT has discovered a new and efficient way to create THC from CBD. This selective method can generate delta 8 or
delta 9 THC.
Jason Lewis, RDT SVP and co-inventor said, “This is an incredible breakthrough for RDT and the industry as a whole. Our technology could revolutionize the way synthetic THC is created so patients around the world can have access to a consistent quality of delta 8 or delta 9. Instead of the industry being dependent on the many complicated variables associated with growing cannabis and the expense of cultivating indoors, we created a method to convert hemp-derived CBD to THC. This is the innovation required to allow pharmaceutical companies to embrace cannabinoid treatments.”
“This process is novel and highly efficient at selectively converting CBD isolate or distillate into synthetic THC,” said Dr. McNulty. “Our collaboration with RDT has resulted in a transformative outcome that we are proud to be involved with. There are numerous high yield derivatives we can control for using naturally derived CBD through the innovative conversion. My team is excited about the possibilities to provide pure cannabinoids for life science companies.”
The PCT application is a follow up to the RDT provisional patent filed on April 5, 2019. Mark Upsdell, RDT CEO, said: “Despite the current COVID situation creating delays around the globe, RDT remains committed to research and innovation. Our filing of this patent is an indication that our continued work with McMaster is aligned with our overall strategy to create unique products aimed at improving patient outcomes. The ability to combine this innovation with our unique QuickStrip™ delivery system will create new opportunities for RDT.”
Allied Corp. (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today’s medical issues is pleased to announce the initiation of a pharmaceutical human clinical PHASE I research trial with MGC Pharmaceuticals.
Under the terms of this agreement, MGC Pharma will provide a comprehensive suite of pharmaceutical services to advance Allied’s pharmaceutical products into human clinical PHASE 1. This trial will test the efficacy and pharmacodynamics of Allied’s pipeline of proprietary cannabis derived drug candidates targeting Post Traumatic Stress Disorder (PTSD). The scope of MGC Pharma’s services will cover clinical research, IMP registration, manufacturing of lab volumes for the research project, drug stability testing, GMP manufacturing and regulatory assistance for obtaining an Investigational Medicinal Product (IMP) number that is needed in order to sell the pharmaceutical product.
Allied has also conducted an extensive prior art review on its previously submitted provisional patents for products AC001 and AC002 and has decided to abandon these. Along with creation of new formulations, representing the conception of new inventions, and its prior art review, Allied will submit patent submissions for products ALID-10 and ALID-11. ALID-10 and ALID-11 will be the products entering into the human clinical trials.
“This agreement with MGC Pharma is a significant milestone for Allied as we continue to make progress towards advancing our first cannabis derived pharmaceutical product into clinical trials for PTSD”, said Calum Hughes, CEO of Allied. “The drug candidates to be developed in our collaboration with MGC Pharma have been validated by Allied’s research through preliminary case study evidence conducted by our corporate physician and the Allied team. We are excited to be working with MGC Pharma, a company with a proven track record in developing cannabis-based drugs and bringing them to market. We look forward to leveraging their technical capabilities to accelerate the development, manufacturing and sales of our first pharmaceutical product for PTSD”.
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF), a provider of high quality cannabis, announced today that it has entered into a licensing agreement with licensed California adult use and medicinal cannabis company HONEY®, one of California's largest full service companies, to supply all of Liberty's dispensaries with the company's full assortment of branded products.
In 2012 HONEY® revolutionized the cannabis industry by becoming the first producer in the world to market distilled cannabis oil in vape cartridges. Today, they provide authentic, full spectrum oil in vape cartridges, applicators, and caps to legal dispensaries and delivery services.
"We are excited to partner with HONEY®, a longstanding pioneer and premium brand in the cannabis space," said Victor Mancebo, Chief Executive Officer of Liberty. "Adding HONEY® to our portfolio of brands creates an immediate distinction between other competitors in the space and reinforces our product offering strategy to provide variety, quality, and price versatility in all of the products we market."
All THC and CBD oil in HONEY cartridges are free of fillers and are lab tested to be 75% +/- cannabinoids. The devices provide the full range of benefits and deliver the precise dosage of cannabinoids with every use.
"We are very excited to be partnering with Liberty to introduce our HONEY® products to the Florida medicinal cannabis market as we started in the California medical market nearly a decade ago," said Peter Tejera, Chief Executive Officer of HONEY®. "We look forward to growing our in-dispensary presence in Florida and this partnership will provide Floridian consumers with a superior choice of high quality, predictable, and consistent product experience second to none."
THC BioMed Intl Ltd. (CSE: THC) announced that its ready-to-drink cannabis beverage shot, THC Kiss, was launched last week on the bccannabis store website and sold out within hours. THC's fulfillment department is now preparing its second order to B.C.
"We are very happy with the launch of THC Kiss so far and excited to offer Canadians a true alternative to smoking cannabis," commented John Miller, President and CEO of THC BioMed.
Each 30ml bottle of THC Kiss contains 10 mg of THC.
The Company also announced that it has entered into a reseller agreement whereby National Cannabis Distribution will buy and resell cannabis products from the Company as one of two exclusive resellers of the Company's products in Saskatchewan.
The term of the Agreement is one year and will automatically renew unless terminated in accordance with the Agreement.
"National Cannabis Distribution has impressed us with its distribution network and business methods. We appreciate that it recognizes the quality and uniqueness of our products and has selected us as a supplier," said Mr. Miller.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800 665 0411
Subscribe to:
Posts (Atom)